| |
| |
|
| Insider
Information: |
Saha Saurabh |
| Relationship: |
Director |
| City: |
Cheshire |
| State: |
X0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
890,245 |
|
|
Indirect Shares
|
38,000 |
|
|
| Direct
Value |
$157,053 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
928,245 |
|
|
| Total
Value |
$157,053 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Centessa Pharmaceuticals Plc |
CNTA |
Chief Executive Office... |
2024-03-31 |
868,187 |
2024-03-31 |
38,000 |
Premium* |
|
|
Clarivate Analytics PLC |
CCC |
Director |
2023-05-04 |
22,058 |
2023-05-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CNTA |
Centessa Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2024-03-31 |
4 |
D |
$11.30 |
$409,772 |
D/D |
(36,263) |
868,187 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2024-02-01 |
4 |
D |
$8.19 |
$215,585 |
D/D |
(26,323) |
904,450 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
144,200 |
930,773 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2023-12-31 |
4 |
D |
$7.96 |
$288,653 |
D/D |
(36,263) |
786,573 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2023-09-30 |
4 |
D |
$6.47 |
$234,622 |
D/D |
(36,263) |
822,836 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2023-06-30 |
4 |
D |
$5.90 |
$213,955 |
D/D |
(36,263) |
859,099 |
0 |
- |
|
| CCC |
Clarivate Analytics PLC |
Director |
– • – |
2023-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
22,058 |
22,058 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
211,400 |
917,375 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2022-12-31 |
4 |
D |
$3.10 |
$136,478 |
D/D |
(44,025) |
705,975 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2022-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
750,000 |
750,000 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2022-06-24 |
4 |
B |
$4.63 |
$46,284 |
I/I |
10,000 |
38,000 |
2.66 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2022-02-02 |
4 |
B |
$9.74 |
$48,700 |
I/I |
5,000 |
28,000 |
2.66 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2021-11-16 |
4 |
B |
$12.28 |
$282,472 |
I/I |
23,000 |
23,000 |
2.66 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
